225 related articles for article (PubMed ID: 16715712)
1. [Treatment outcomes in patients with unfavorable histologic type of endometrial carcinoma].
Litvinova TM; Kosenko IA
Vopr Onkol; 2006; 52(1):89-91. PubMed ID: 16715712
[TBL] [Abstract][Full Text] [Related]
2. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
[TBL] [Abstract][Full Text] [Related]
3. [Treatment results in endometrial cancer in patients of reproductive age].
Vishnevskaia EE
Vopr Onkol; 2006; 52(4):451-4. PubMed ID: 17024821
[TBL] [Abstract][Full Text] [Related]
4. Endometrial giant cell carcinoma: a case series and review of the spectrum of endometrial neoplasms containing giant cells.
Mulligan AM; Plotkin A; Rouzbahman M; Soslow RA; Gilks CB; Clarke BA
Am J Surg Pathol; 2010 Aug; 34(8):1132-8. PubMed ID: 20588176
[TBL] [Abstract][Full Text] [Related]
5. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study.
Sutton G; Axelrod JH; Bundy BN; Roy T; Homesley HD; Malfetano JH; Mychalczak BR; King ME
Gynecol Oncol; 2005 Jun; 97(3):755-63. PubMed ID: 15913742
[TBL] [Abstract][Full Text] [Related]
6. Endometrial cancer in premenopausal women 45 years and younger.
Gitsch G; Hanzal E; Jensen D; Hacker NF
Obstet Gynecol; 1995 Apr; 85(4):504-8. PubMed ID: 7898824
[TBL] [Abstract][Full Text] [Related]
7. Clear-cell and papillary serous cancer: treatment options.
Tropé C; Kristensen GB; Abeler VM
Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):433-46. PubMed ID: 11476564
[TBL] [Abstract][Full Text] [Related]
8. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group.
Sutton G; Axelrod JH; Bundy BN; Roy T; Homesley H; Lee RB; Gehrig PA; Zaino R
Gynecol Oncol; 2006 Feb; 100(2):349-54. PubMed ID: 16213007
[TBL] [Abstract][Full Text] [Related]
10. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications.
Aquino-Parsons C; Lim P; Wong F; Mildenberger M
Gynecol Oncol; 1998 Oct; 71(1):83-6. PubMed ID: 9784324
[TBL] [Abstract][Full Text] [Related]
11. Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.
Chang-Halpenny CN; Natarajan S; Hwang-Graziano J
Gynecol Oncol; 2013 Dec; 131(3):598-603. PubMed ID: 24135679
[TBL] [Abstract][Full Text] [Related]
12. Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases.
Scarfone G; Secomandi R; Parazzini F; Viganò R; Mangili G; Frigerio L; Villa A; Tateo S; Ricci E; Bolis G
Arch Gynecol Obstet; 2013 Feb; 287(2):351-6. PubMed ID: 23100038
[TBL] [Abstract][Full Text] [Related]
13. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
[TBL] [Abstract][Full Text] [Related]
14. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
[TBL] [Abstract][Full Text] [Related]
15. Concomitant endometrial hyperplasia in patients with endometrial carcinoma.
Gücer F; Reich O; Tamussino K; Bader AA; Pieber D; Schöll W; Haas J; Petru E
Gynecol Oncol; 1998 Apr; 69(1):64-8. PubMed ID: 9571000
[TBL] [Abstract][Full Text] [Related]
16. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
Havrilesky LJ; Secord AA; O'Malley DM; Broadwater G; Bae-Jump V; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
[TBL] [Abstract][Full Text] [Related]
17. Clear cell carcinoma of the endometrium: a biological and clinical enigma.
Gadducci A; Cosio S; Spirito N; Cionini L
Anticancer Res; 2010 Apr; 30(4):1327-34. PubMed ID: 20530448
[TBL] [Abstract][Full Text] [Related]
18. Survival after multimodality treatment for stage IIIC endometrial cancer.
Katz LA; Andrews SJ; Fanning J
Am J Obstet Gynecol; 2001 May; 184(6):1071-3. PubMed ID: 11349160
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of endometrial carcinoma patients aged 45 years and younger].
Gao JS; Shen K; Lang JH; Huang HF; Pan LY; Wu M; Jin Y; Chen QH
Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):159-61. PubMed ID: 15130373
[TBL] [Abstract][Full Text] [Related]
20. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.
Pothuri B; Ramondetta L; Eifel P; Deavers MT; Wilton A; Alektiar K; Barakat R; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):948-51. PubMed ID: 16870239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
